ARENA PHARMACEUTICALS INC (ARNA)

Common Stock

99.99  +0.06 (+0.06%)

After market: 99.99 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
806.4M
4,380.00%		300K
-99.96%		54K
-82.00%		31.031M
EBITDA
YoY % growth
500.5M
454.96%		-422.8M
-184.48%		-541.789M
-28.14%		N/AN/AN/AN/A
EBIT
YoY % growth
497.3M
443.44%		-426.7M
-185.80%		-545.661M
-27.88%		N/AN/AN/AN/A
Operating Margin
61.67%-142,233.33%-1,010,483.33%N/AN/AN/AN/A
EPS
YoY % growth
7.88
363.55%		-7.40
-193.91%		-8.84
-19.46%		-8.61

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		-2.26
Revenue
Q2Q % growth		863.603K
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth		 -2.39
-13.81%		-2.31-0.08-3.59%
Q3 2021
Q2Q % growth		 -2.07
-22.49%		-2.580.5119.89%
Q2 2021
Q2Q % growth		 -2.40
-49.07%		-2.24-0.16-6.94%
Q1 2021
Q2Q % growth		 -1.98
1.00%		-2.200.2210.06%
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth		 54K
∞%		678.667K-624.667K-92.04%
Q3 2021
Q2Q % growth		 693.6K-693.6K-100.00%
Q2 2021
Q2Q % growth		 826.812K-826.812K-100.00%
Q1 2021
Q2Q % growth
-100.00%		582.859K-582.859K-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A